FDA lifts penalties on Boston Scientific (New Ratings)
NEW YORK, April 16 (newratings.com) Medical device manufacturer Boston Scientific ( BSX.NYS ) Monday announced that the Food and Drug Administration (FDA) has lifted penalties imposed on the company during 2005.

FDA clears Guidant plant (Pioneer Press)
It took a year, but Boston Scientific finally can start pumping new products out of its purchase of Guidant.

FDA Announces Recommendations to Reauthorize Medical Device User Fee Program (U. S. Food and Drug Administration)
FDA is accepting public comments on the proposal for the next 30 days and is holding a public meeting on April 30.